Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjalling Bosse

Showing results (11-20 of 167) with videos related to

Pageof 17
Sort By:
Current Oncology Reports|August 2, 2019
Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk FactorsBastiaan G Wortman, Remi A Nout, Tjalling Bosse, et al.
Expert Review of Anticancer Therapy|October 9, 2018
Adjuvant therapy for high-risk endometrial cancer: recent evidence and future directionsStephanie M De Boer, Remi A Nout, Tjalling Bosse, et al.
Journal of the National Cancer Institute|August 23, 2021
Response to Nahshon and LavieCornelis D de Kroon, Marthe M de Jonge, Tjalling Bosse, et al.
Critical Reviews in Oncology/Hematology|June 5, 2020
PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancerCathalijne C B Post, Anneke M Westermann, Tjalling Bosse, et al.
The Journal of Bone and Joint Surgery. American Volume|March 7, 2014
Temporary presence of myofibroblasts in human elbow capsule after traumaJob N Doornberg, Tjalling Bosse, Mark S Cohen, et al.
Histopathology|June 27, 2024
Practical guidance for assessing and reporting lymphovascular space invasion (LVSI) in endometrial carcinomaElke E M Peters, Marisa R Nucci, C Blake Gilks, et al.
BMC Cancer|January 24, 2018
A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case reportArie J Verschoor, Fabiënne A R M Warmerdam, Tjalling Bosse, et al.
Molecular and Cellular Biology|August 31, 2006
Gata4 is essential for the maintenance of jejunal-ileal identities in the adult mouse small intestineTjalling Bosse, Christina M Piaseckyj, Ellen Burghard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 21, 2020
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapyAnne Sophie V M van den Heerik, Nanda Horeweg, Stephanie M de Boer, et al.
Nature Reviews. Cancer|January 30, 2016
A panoply of errors: polymerase proofreading domain mutations in cancerEmily Rayner, Inge C van Gool, Claire Palles, et al.
Pageof 17

Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
Current Oncology Reports|August 2, 2019
Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk FactorsBastiaan G Wortman, Remi A Nout, Tjalling Bosse, et al.
Expert Review of Anticancer Therapy|October 9, 2018
Adjuvant therapy for high-risk endometrial cancer: recent evidence and future directionsStephanie M De Boer, Remi A Nout, Tjalling Bosse, et al.
Journal of the National Cancer Institute|August 23, 2021
Response to Nahshon and LavieCornelis D de Kroon, Marthe M de Jonge, Tjalling Bosse, et al.
Critical Reviews in Oncology/Hematology|June 5, 2020
PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancerCathalijne C B Post, Anneke M Westermann, Tjalling Bosse, et al.
The Journal of Bone and Joint Surgery. American Volume|March 7, 2014
Temporary presence of myofibroblasts in human elbow capsule after traumaJob N Doornberg, Tjalling Bosse, Mark S Cohen, et al.
Histopathology|June 27, 2024
Practical guidance for assessing and reporting lymphovascular space invasion (LVSI) in endometrial carcinomaElke E M Peters, Marisa R Nucci, C Blake Gilks, et al.
BMC Cancer|January 24, 2018
A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case reportArie J Verschoor, Fabiënne A R M Warmerdam, Tjalling Bosse, et al.
Molecular and Cellular Biology|August 31, 2006
Gata4 is essential for the maintenance of jejunal-ileal identities in the adult mouse small intestineTjalling Bosse, Christina M Piaseckyj, Ellen Burghard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 21, 2020
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapyAnne Sophie V M van den Heerik, Nanda Horeweg, Stephanie M de Boer, et al.
Nature Reviews. Cancer|January 30, 2016
A panoply of errors: polymerase proofreading domain mutations in cancerEmily Rayner, Inge C van Gool, Claire Palles, et al.
Pageof 17